Mild nausea; This is a spontaneous report from a contactable consumer (patient). A 73-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 28Jan2021 18:30 at single dose (right arm) for covid-19 immunization. Medical history included allergies, asthma and Clostridium difficile (c.dif). Patient had allergies to medications, food or other products. The patient was not pregnant. Concomitant medication included rosuvastatin within 2 weeks of vaccination. The patient received other vaccine within 4 weeks prior to Covid vaccine included 1 dose of pneumonia vaccine on 07Jan2021 at a clinic. On 28Jan2021 18:30, the patient experienced mild nausea. Treatment was not received for the event. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, patient has not patient been tested for covid-19. Outcome of event was recovered on an unspecified date.  Information on the lot/batch number has been requested.